Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 2,935.00
+155.00 (5.58%)
Apr 16, 2026, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 86.59 billion as of April 16, 2026. Its market cap has increased by 22.85% in one year.
Market Cap
86.59B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2,935.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 86.59B, a decrease of -82.05%. That is a compound annual growth rate of -21.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 86.59B | 2.62% |
| Dec 30, 2025 | 84.38B | -20.98% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.10T |
| Celltrion | 41.73T |
| ALTEOGEN | 18.89T |
| Samsung Epis Holdings | 13.44T |
| LabGenomics | 94.21B |
| IMB Dx | 93.36B |
| Humasis | 90.64B |
| PharmGen Science | 84.69B |